Dermatitis, Seborrheic: Clinical Trials

56 trials for Dermatitis, Seborrheic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

39 completed, 8 unknown, 3 not yet recruiting, 3 recruiting. 15 Not applicable, 13 Phase 2, 7 Phase 3, 7 Phase 4, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 9, Not yet recruiting 2, Terminated 2, Recruiting 1, Unknown 1
Phase 213Completed 11, Terminated 1, Unknown 1
Phase 37Completed 5, Not yet recruiting 1, Unknown 1
Phase 47Completed 6, Unknown 1
Phase 13Completed 1, Recruiting 1, Unknown 1
Early Phase 12Completed 1, Recruiting 1

Follow Dermatitis, Seborrheic: new trials by email Literature Review of Dermatitis, Seborrheic trials Research Report on Dermatitis, Seborrheic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
TRIDERM D.S. Crema Normalizzante for Neonatal Hyperseborrhea (Cradle Cap) and Associated Cutaneous Manifestations of Mild-to-Moderate Seborrheic Dermatitis in Children Aged 0 to 3 Years
TRIDERM D.S. Crema Normalizzante - Cradle Cap, Seborrheic Dermatitis
Not applicableNot yet recruitingICIM International S.r.l.202026-10-012026-10-06
Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis
Roflumilast Foam 0.3%, Vehicle foam - Seborrheic Dermatitis
Phase 3Not yet recruitingHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.3092026-08-242026-08-21
ZYG24002 Lotion to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy in Adult Patients With Mild to Moderate Seborrheic Dermatitis
ZYG24002 0.5%, ZYG24002 0.75%, ZYG24002 1% - Seborrheic Dermatitis
Phase 1RecruitingSinomune Pharmaceutical Co., Ltd482026-04-242026-06-17
Sebum Metabolomics and Lipidomics for Clinical Applications
Sebutape sampling, Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment) - Acne, Atopic Dermatitis
Not applicableNot yet recruitingNational Taiwan University Hospital2002026-04-012026-04-24
Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis
Antioxidant moisturizing serum - Seborrheic Dermatitis on the Face
Not applicableCompletedInstitute of Dermatology, Thailand132026-03-062026-07-28
Effect of 0.75% Piroctone Olamine Shampoo on the Hair and Scalp Microbiota of Hijab-Wearing Women With Seborrheic Dermatitis in Indonesia
Piroctone Olamine 0.75% Shampoo, Ketoconazole Shampoo, 2% - Seborrheic Dermatitis
Phase 4CompletedUniversitas Indonesia862026-01-122026-09-03
The Effectiveness of Itraconazole Pulse Therapy vs Topical 2% Ketoconazole in the Treatment of Moderate to Severe Seborrheic Dermatitis of Scalp.
Itraconazole (200 mg), Ketoconazole 2% - Seborrheic Dermatitis
Early Phase 1RecruitingCombined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan802026-01-072026-07-29
Safety and Efficacy of a Topical Cream in Mild-to-Moderate Seborrheic Dermatitis
Microbiome-Powered Cream, Placebo Hair Cream - Seborrheic Dermatitis
Not applicableCompletedNovoBliss Research Pvt Ltd342025-07-212026-08-10
Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic Dermatitis
Itraconazole, Terbinafine 1% cream, Hydrocortisone 1% cream - Seborrheic Dermatitis
Phase 4CompletedCan Tho University of Medicine and Pharmacy762025-07-072026-10-30
A Study on Scalp Health and Integrated Scalp Management Protocols for Hair Transplant Patients
Intervention Name:Test shampoo + basic shampoo for scalp care, Basic scalp care shampoo - Hair Transplantation, Seborrheic Dermatitis
Not applicableRecruitingChinaNorm1202025-02-212026-06-11
A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic Dermatitis
RV5263A - WS0060, RV5263A - LC3302, Standard Medical Care (SMC) - Seborrheic Dermatitis
Not applicableCompletedPierre Fabre Dermo Cosmetique902025-02-042026-05-08
Phenotypic and Functional Profile of Peripheral Blood Lymphomonocytes in Seborrheic Dermatitis.
Seborrheic Dermatitis, Dietary Habits
CompletedSan Gallicano Dermatological Institute IRCCS302024-06-192025-12-22
Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists
AI-based medical device for aided diagnosis in Dermatology - Pustular Psoriasis (PP), Generalized Pustular Psoriasis (GPP)
CompletedAI Labs Group S.L152024-06-012026-02-24
Ozonated Oil Emulsion for Seborrhea in Women
Ozonated oil-based cosmetic emulsion, Matched vehicle control - Cosmetic Management of Oily Scalp
Not applicableCompletedChadi Khatib662024-04-062026-10-23
PDE4 Inhibition in Seborrheic Dermatitis and Papulopustular Rosacea
PF-07038124, Placebo Ointment - Seborrheic Dermatitis, Papulopustular Rosacea
Phase 2TerminatedIcahn School of Medicine at Mount Sinai322023-07-192026-08-14
The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis
No Intervention - Acne, Melasma
Not applicableUnknownIntegrative Skin Science and Research1502023-06-062024-08-27
Ruxolitinib in Seborrheic Dermatitis
Ruxolitinib 1.5% Cream - Seborrheic Dermatitis
Phase 2CompletedIcahn School of Medicine at Mount Sinai452022-11-152025-05-06
Cleansing Device for the Treatment of Scalp and Hair Conditions
Off-brand Waterpik® - Dandruff, Seborrheic Dermatitis
Not applicableTerminatedUniversity of Minnesota22022-05-272026-09-04
Study to Evaluate the Safety of Sebryl® and Sebryl Plus® in Seborrheic Dermatitis and Psoriasis of Scalp
Allantoin/ Coal Tar/ Clioquinol, Allantoin/ Coal Tar/ Clioquinol/ Triclosan - Seborrheic Dermatitis, Psoriasis of Scalp
CompletedLaboratorios Silanes S.A. de C.V.902021-11-292022-04-13
A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe
Cyproterone Acetate (Androcur, BAY94-8367) - Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea, Hypersexuality in Men
CompletedBayer6002021-10-182022-01-12

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Acne Vulgaris (6)  ·  Dermatitis, Atopic (4)  ·  Psoriasis (4)  ·  Rosacea (4)  ·  Alopecia (3)  ·  Dandruff (3)  ·  Dermatitis (3)  ·  Acquired Immunodeficiency Syndrome (2)  ·  Complement component 5 deficiency (2)  ·  Parkinson Disease (2)  ·  Uterine Cervical Dysplasia (2)  ·  Acne Conglobata (1)  ·  Acute Generalized Exanthematous Pustulosis (1)  ·  Anemia (1)

Broader conditions

Sebaceous Gland Diseases (56)  ·  Skin Diseases, Eczematous (56)  ·  Skin Diseases, Papulosquamous (56)  ·  Skin and Connective Tissue Diseases (56)  ·  Skin Diseases (55)  ·  Dermatitis (53)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Immune System Diseases (7)  ·  Acneiform Eruptions (6)  ·  Signs and Symptoms (6)  ·  Hypersensitivity (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4)  ·  Disease Attributes (4)  ·  Genetic Diseases, Inborn (4)  ·  Hypersensitivity, Immediate (4)

Interventions

Ketoconazole (4)  ·  Ciclopirox (2)  ·  Itraconazole (2)  ·  Tacrolimus (2)  ·  Allantoin (1)  ·  Aminolevulinic Acid (1)  ·  Bacitracin (1)  ·  Biopsy (1)  ·  Botulinum Toxins (1)  ·  Cannabidiol (1)  ·  Clioquinol (1)  ·  Coal Tar (1)  ·  Cosmetics (1)  ·  Cyproterone Acetate (1)  ·  HIV Testing (1)

Sponsors

Arcutis Biotherapeutics, Inc. (3)  ·  Pierre Fabre Dermo Cosmetique (3)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Moberg Pharma AB (2)  ·  AI Labs Group S.L (1)  ·  Allergisa Pesquisa Dermato-Cosmetica LTDA (1)  ·  Amorepacific Corporation (1)  ·  Ann & Robert H Lurie Children's Hospital of Chicago (1)  ·  Aria Aesthetics Inc. (1)  ·  Ascension Health (1)  ·  Astion Pharma A/S (1)  ·  Bayer (1)  ·  Boston University (1)  ·  Can Tho University of Medicine and Pharmacy (1)  ·  Center for Epidemiology and Health Research, Germany (1)

Countries

United States (19)  ·  France (5)  ·  Canada (3)  ·  China (3)  ·  Netherlands (3)  ·  Germany (2)  ·  Italy (2)  ·  Poland (2)  ·  Spain (2)  ·  Sweden (2)  ·  Brazil (1)  ·  India (1)  ·  Indonesia (1)  ·  Mexico (1)  ·  Pakistan (1)

Top investigators

David Berk, MD (3)  ·  Benjamin Ungar, MD (2)  ·  Adilson Costa, MD (1)  ·  Aditya Gupta, M.D., Ph.D. (1)  ·  Aibing M Guo, M.D. (1)  ·  Ann K Sullivan, MBBS FRCP (1)  ·  Antonio Martorell, PhD (1)  ·  BeomJoon Kim, Professor (1)  ·  Bernard Goffe, MD (1)  ·  Boni Elewski, MD (1)  ·  Byung-Soo Kim, Ph.D. (1)  ·  Dang Khoa Dang Tran, MD (1)  ·  David Cunningham, PhD FRCP (1)  ·  Debra Breneman, MD (1)

Results publications

PMID 23377341, PMID 23388687, PMID 28458770, PMID 37133856, PMID 38466972, PMID 39731054, PMID 40498389, PMID 41175336, PMID 41680533, PMID 41893958